Daiichi Sankyo (United States)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
50%
Total
Publications
2K
Total Open
Publications
1K
Total
Citations
70K
Open Access
Percentage
50%
Total
Publications
2K
Total Open
Publications
1K
Total
Citations
70K
Breakdown
Publisher Open
23%
Both
22%
Other Platform Open
5%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
300
Hybrid 26%
244
No Guarantees 42%
387
Other Platform Open
Domain 76%
420
Institution 48%
264
Other Internet 11%
62
Preprint 4%
22
Public 2%
9
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 427 |
doaj.org OAI-PMH Repository | Institution | 125 |
Unknown Repository | Other Internet | 43 |
Royal Netherlands Academy of Arts and Sciences | Institution | 29 |
DOI | Other Internet | 24 |
Leiden University | Institution | 22 |
LA Referencia | Institution | 16 |
kuleuven.be OAI-PMH Repository | Institution | 16 |
California Digital Library | Institution | 13 |
National Institute of Informatics | Institution | 12 |